DK315187A - Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser - Google Patents
Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekserInfo
- Publication number
- DK315187A DK315187A DK315187A DK315187A DK315187A DK 315187 A DK315187 A DK 315187A DK 315187 A DK315187 A DK 315187A DK 315187 A DK315187 A DK 315187A DK 315187 A DK315187 A DK 315187A
- Authority
- DK
- Denmark
- Prior art keywords
- unsolutable
- immunic
- complexs
- antibodies
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
- C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6056—Antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87682886A | 1986-06-20 | 1986-06-20 | |
US07/024,632 US4879225A (en) | 1986-06-20 | 1987-03-11 | Enhanced production of antibodies utilizing insolubilized immune complexes |
Publications (2)
Publication Number | Publication Date |
---|---|
DK315187D0 DK315187D0 (da) | 1987-06-19 |
DK315187A true DK315187A (da) | 1987-12-21 |
Family
ID=26698676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK315187A DK315187A (da) | 1986-06-20 | 1987-06-19 | Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser |
Country Status (7)
Country | Link |
---|---|
US (1) | US4879225A (da) |
EP (1) | EP0251065A3 (da) |
JP (1) | JPS63258496A (da) |
CN (1) | CN87105716A (da) |
AU (1) | AU615628B2 (da) |
DK (1) | DK315187A (da) |
NO (1) | NO872581L (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2220140A (en) * | 1988-05-05 | 1990-01-04 | Nat Res Dev | Immunogenic complex and its use in vaccination |
WO1991017187A2 (en) | 1990-04-18 | 1991-11-14 | The Regents Of The University Of California | A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION |
US5723115A (en) * | 1991-05-02 | 1998-03-03 | W. Alton Jones Cell Science Center, Inc. | Inhibition of adipose tissue development and obesity |
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5283066A (en) * | 1992-02-19 | 1994-02-01 | Development Center For Biotechnology | Method of stimulating an immune response by using a hapten |
CA2098960C (en) * | 1992-07-10 | 2004-11-02 | Richard Barner | Bio specifically recognizing surfaces on solid supports and method for their preparation |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
ATE485825T1 (de) | 1993-01-28 | 2010-11-15 | Boston Scient Ltd | Therapeutische inhibitoren der zellen der glatten gefässmuskulatur |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US7611533B2 (en) | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
GB9606425D0 (en) * | 1996-03-27 | 1996-06-05 | Binding Site Ltd | Improvements in and relating to the production of antibodies and test kits incorporating antibodies |
US7361346B1 (en) * | 1996-05-15 | 2008-04-22 | Altarex Corp. | Therapeutic compositions that produce an immune response |
NZ516264A (en) * | 1996-05-15 | 2002-04-26 | Altarex Inc | Cancer antigens CA125 (multiple epitote) recognised by OC125, M11, B43.13, B27.1, where B43.13 is used as a binding agent to elicit host immune response as a vaccination method against cancer |
US8038994B2 (en) * | 1996-05-15 | 2011-10-18 | Quest Pharmatech Inc. | Combination therapy for treating disease |
US20080220012A1 (en) * | 1996-05-15 | 2008-09-11 | Ragupathy Madiyalakan | Therapeutic Compositions that alter the immune response |
US7318921B2 (en) * | 1996-05-15 | 2008-01-15 | Altarex Medical Corp. | Therapeutic compositions that alter the immune response |
US20060159688A1 (en) * | 1996-05-15 | 2006-07-20 | Ragupathy Madiyalakan | Method for diagnosing efficacy of xenotypic antibody therapy |
EP0975340B2 (en) | 1997-03-31 | 2009-10-28 | Boston Scientific Limited | Therapeutic inhibitor of vascular smooth muscle cells |
CA2697598A1 (en) | 1999-01-12 | 2000-07-20 | Cambridge Enterprise Limited | Compounds and methods to inhibit or augment an inflammatory response |
US7009040B2 (en) * | 2003-01-21 | 2006-03-07 | Arius Research, Inc. | Cancerous disease modifying antibodies |
US6613083B2 (en) | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
CA2481796A1 (en) * | 2002-04-11 | 2003-10-23 | Altarex Medical Corporation | Binding agents and their use in targeting tumor cells |
US7393531B2 (en) * | 2003-01-21 | 2008-07-01 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of MCSP |
US7468254B2 (en) * | 2003-01-21 | 2008-12-23 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of MCSP |
JP3600231B1 (ja) * | 2003-09-30 | 2004-12-15 | 森永製菓株式会社 | イムノアッセイ |
WO2019199918A1 (en) * | 2018-04-11 | 2019-10-17 | Cowan Fred M | Compositions and methods for prevention and treatment of immune complex disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3063736D1 (en) * | 1979-03-27 | 1983-07-21 | Nat Res Dev | Improvements in or relating to immunological preparations |
IL63220A (en) * | 1981-07-01 | 1985-09-29 | Yeda Res & Dev | Process for production of polyacrolein microspheres |
US4471058A (en) * | 1982-07-26 | 1984-09-11 | Board Of Trustees Operating Michigan State University | Method for the detection and/or determination of a polyvalent antigen using at least two different monoclonal antibodies |
US4693966A (en) * | 1983-03-11 | 1987-09-15 | Sloan-Kettering Institute For Cancer Research | Human monoclonal antibodies from lymphocytes of patients with malignant melanoma |
FR2558165B1 (fr) * | 1984-01-17 | 1986-07-04 | Anvar | Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages |
-
1987
- 1987-03-11 US US07/024,632 patent/US4879225A/en not_active Expired - Fee Related
- 1987-06-19 DK DK315187A patent/DK315187A/da not_active Application Discontinuation
- 1987-06-19 EP EP87108792A patent/EP0251065A3/en not_active Ceased
- 1987-06-19 AU AU74496/87A patent/AU615628B2/en not_active Ceased
- 1987-06-19 NO NO872581A patent/NO872581L/no unknown
- 1987-06-19 CN CN198787105716A patent/CN87105716A/zh active Pending
- 1987-06-20 JP JP62152442A patent/JPS63258496A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPS63258496A (ja) | 1988-10-25 |
AU615628B2 (en) | 1991-10-10 |
AU7449687A (en) | 1987-12-24 |
CN87105716A (zh) | 1988-06-08 |
EP0251065A3 (en) | 1989-08-30 |
NO872581D0 (no) | 1987-06-19 |
US4879225A (en) | 1989-11-07 |
NO872581L (no) | 1987-12-21 |
DK315187D0 (da) | 1987-06-19 |
EP0251065A2 (en) | 1988-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK315187D0 (da) | Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser | |
DK238988D0 (da) | Fremgangsmaade til fremstilling af 4-acyloxy-3-hydroxyethyl-azetidinoner | |
DK65185A (da) | Fremgangsmaade til fremstilling af antistof | |
DK129085D0 (da) | Fremgangsmaade til fremstilling af proteiner | |
FI881866A0 (fi) | Perunakuidun valmistusmenetelmä | |
DK104487D0 (da) | Fremgangsmaade til fremstilling af kanelsyrer | |
DK78388A (da) | Fremgangsmaade til fremstilling af 4-acetoxy-3-hydroxyethyl-azetidinon | |
DK28788A (da) | Fremgangsmaade til fremstilling af alkansulfonamider | |
DK471588D0 (da) | Fremgangsmaade til fremstilling af polymerer | |
DK117487A (da) | Fremgangsmaade til fremstilling af inulase | |
DK533287A (da) | Fremgangsmaade til fremstilling af azetidinoner | |
DK329685A (da) | Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere | |
DK361387A (da) | Fremgangsmaade til fremstilling af piperidinopyrimidin | |
DK190187D0 (da) | Fremgangsmaade til fremstilling af n-aminophthalimid | |
DK60287A (da) | Fremgangsmaade til fremstilling af 4-acetyl-isoquinolinon-forbindelser | |
DK203887A (da) | Fremgangsmaade til fremstilling af roerformede fiberemner | |
DK184687A (da) | Fremgangsmaade til fremstilling af diacetonesorbose | |
DK450087D0 (da) | Fremgangsmaade til fremstilling af proteiner | |
DK280187A (da) | Fremgangsmaade til fremstilling af metalloproteinkonjugater | |
DK350288D0 (da) | Fremgangsmaade til fremstilling af n-epoxypropyllactamer | |
DK346987D0 (da) | Fremgangsmaade til fremstilling af tetrahydrofuranforbindelser | |
DK142788D0 (da) | Fremgangsmaade til fremstilling af chlorerede olefiner | |
DK555087A (da) | Fremgangsmaade til fremstilling af n-acyl-n-alkyl-2,6-dialkyl-3-chloraniliner | |
DK646188D0 (da) | Fremgangsmaade til fremstilling af halogenalkyllactamer | |
DK589986A (da) | Fremgangsmaade til fremstilling af polymerer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |